NCT07328724

Critical Illness After Hematopoietic Cell Transplantation

Critical Illness Among Recipients of Hematopoietic Cell Transplantation (CARE-HCT): a Prospective, Multicenter Observational Study in China

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 4,000 (estimated)
• Sponsor: Peking University People's Hospital · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This is a prospective, multicenter observational trial for patients who develop critical illness after hematopoietic cell transplantation. Patients who are admitted to the intensive care unit after undergoing hematopoietic cell transplantation at the participating medical centers will be enrolled in this study. The clinical characteristics, laboratory profiles, managements, and clinical outcomes will be prospectively collected.

Conditions

• Critical Illness
• Ventilated Patients
• Hematopoetic Stem Cell Transplantation
• Transplant Complication

Timeline

• Start date: 2026-01-01
• Primary completion: 2036-06-30
• Completion: 2036-12-31
• First posted: 2026-01-09
• Last updated: 2026-01-09

Locations

6 sites across 1 country: China